Edesa Biotech (EDSA) Cost of Revenue (2013 - 2020)
Edesa Biotech (EDSA) reported Cost of Revenue of $2,314 for fiscal Q4 2020 (quarter ended Sep 30, 2020), up 57.2% from the prior quarter.
Powered by 
Analysis
Edesa Biotech (EDSA) Cost of Revenue (2013 - 2020) Analysis & Trends
For FY2020 (ended Sep 30, 2020), Edesa Biotech posted Cost of Revenue of $17,601, down 82.6% from FY2019.
- Cost of Revenue has declined for four consecutive fiscal years, with a five-year compound annual growth rate of -50.3% (FY2015 to FY2020).
- By fiscal year, Cost of Revenue came in at $101,286 in FY2019 (-24.0%), $133,316 in FY2018 (-46.7%), $250,042 in FY2017 (-69.5%) and $818,566 in FY2016 (+40.9%).
- Five-year quarterly Cost of Revenue spans a low of $1,472 in fiscal Q3 2020 and a high of $312,063 in fiscal Q1 2016.
- The high point for year-over-year Cost of Revenue in five years was fiscal Q1 2016 (growth of 225.3%); the low point was fiscal Q1 2018 (a decline of 96.4%).
- Per Business Quant data, the three fiscal quarters before Q4 2020 came in at $1,472 (Q3 2020), $10,037 (Q2 2020) and $3,778 (Q1 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Edesa Biotech | 26.68 Mn | -18.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 2,314.00 |
| Jun 30, 2020 | 1,472.00 |
| Mar 31, 2020 | 10,037.00 |
| Dec 31, 2019 | 3,778.00 |
| Sep 30, 2018 | 19,277.00 |
| Jun 30, 2018 | 45,615.00 |
| Mar 31, 2018 | 65,623.00 |
| Dec 31, 2017 | 2,801.00 |
| Sep 30, 2017 | 22,479.00 |
| Jun 30, 2017 | 77,555.00 |
| Mar 31, 2017 | 71,443.00 |
| Dec 31, 2016 | 78,565.00 |
| Sep 30, 2016 | 117,613.00 |
| Jun 30, 2016 | 119,989.00 |
| Mar 31, 2016 | 268,901.00 |
| Dec 31, 2015 | 312,063.00 |
| Sep 30, 2015 | 9,785.00 |
| Jun 30, 2015 | 231,999.00 |
| Mar 31, 2015 | 243,115.00 |
| Dec 31, 2014 | 95,925.00 |
API Access
Edesa Biotech Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();